Improved Ultrasound Evaluation Method for Diagnosing Nonalcoholic Fatty Pancreatic Disease: Correlation with MRI mDixon-Quant

Improved Ultrasound Evaluation Method for Diagnosing Nonalcoholic Fatty Pancreatic Disease: Correlation with MRI mDixon-Quant

Purpose: Early diagnosis and treatment of non-alcoholic fatty pancreatic disease (NAFPD) can effectively intervene in the development of type 2 diabetes. This study aimed to evaluate the utility of an improved ultrasound method for diagnosing NAFPD. Methods: All patients underwent abdominal ultrason...

Full description

Saved in:

Bibliographic Details
Main Author:	Lin Jiaojiao, Ke Helin, Xu Shaodan, Xiao Yang, Han Lina, Lyu Guorong, Li Shilin
Format:	Article
Language:	English
Published:	Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2025-06-01
Series:	Advanced Ultrasound in Diagnosis and Therapy
Subjects:	\|mri-pdff\|ultrasound\|pancreatic steatosis
Online Access:	https://www.journaladvancedultrasound.com/fileup/2576-2516/PDF/1751848747154-1320781004.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The diagnostic value of MRI-PDFF in hepatic steatosis of patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
by: Yue-Xia Zhang, et al.
Published: (2025-07-01)

Quantification of liver fat fraction using T1-weighted mDixon MRI in young patients with ataxia telangiectasia undergoing whole-body MRI: an exploratory study
by: Soma Kumasaka, et al.
Published: (2025-06-01)

Effect of adipose tissue deposition on insulin resistance in middle‐aged and elderly women: Based on QCT and MRI mDIXON‐Quant
by: Ying Liu, et al.
Published: (2025-02-01)

Application Research of mDIXON-Quant Quantitative T2* Values and FF Values in Cervical Intervertebral Disc Degeneration
by: Peng LIU, et al.
Published: (2025-01-01)

Correlation analysis between the mDIXON-quant fat quantification parameters of the infrapatellar fat pad and the severity of knee osteoarthritis
by: Bao-Gen Zhao, et al.
Published: (2025-03-01)

Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content
by: Haoxiang Zhu, et al.
Published: (2025-01-01)

Políticas públicas na faixa de fronteira do Brasil: PDFF, CDIF e as políticas de segurança e defesa
by: Camilo Pereira Carneiro Filho, et al.
Published: (2019-09-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial
by: Bas Groenewegen, et al.
Published: (2025-12-01)

Noninvasive Quantification of Hepatic Steatosis Using Ultrasound‐Derived Fat Fraction (CHESS2303): A Prospective Multicenter Study
by: Yunlin Huang, et al.
Published: (2025-03-01)

Multimodality comparison of aorta morphology in patients with aortopathy: 4D flow CMR, CTA, mDIXON
by: Bastiaan J.C. Te Kiefte, et al.
Published: (2025-06-01)

A deep learning aided bone marrow segmentation of quantitative fat MRI for myelofibrosis patients
by: Humera Tariq, et al.
Published: (2025-05-01)

Assessing the impact of liver fat fraction on portal hemodynamics in nonalcoholic fatty liver disease using MRI proton density fat fraction and MRI 4D Flow
by: Li-Zhen Wang, et al.
Published: (2025-08-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

Methods and validation of velacur determined fat fraction in patients with MASLD
by: Mohammad Honarvar, et al.
Published: (2024-12-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)

Adherence to plant based diets reduce the risk of hepatic fibrosis in nonalcoholic fatty liver disease
by: Mahsa Miryan, et al.
Published: (2025-05-01)

Association of dietary glycemic index and glycemic load with pancreatic steatosis: a case control study
by: Mohammad Bahrizadeh, et al.
Published: (2025-03-01)

Impact of intermittent fasting versus vitamin D on high fat fructose-induced pancreatic steatosis: possible role of aquaporins
by: Basma Adel Khattab, et al.
Published: (2025-05-01)

Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes
by: Orsu Prabhakar, et al.
Published: (2021-01-01)

Utility of the serum alanine aminotransferase to high density lipoprotein cholesterol ratio in evaluating nonalcoholic fatty liver disease and liver fibrosis
by: Yanyan Xuan, et al.
Published: (2025-07-01)

Fatty pancreas disease in newly diagnosed type 2 diabetes patients: a case–control study on relationships with glycemic control and exocrine function
by: Tahsin Taner Karaevren, et al.
Published: (2025-03-01)

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease
by: I. I. Vakalyuk, et al.
Published: (2018-03-01)

A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
by: Jie Chen, et al.
Published: (2023-10-01)

Imaging and evaluation of cervicothoracic lymphatic drainage pathways in single ventricle patients with Fontan circulation using the mDixon steady state MR angiography
by: Monika Huhndorf, et al.
Published: (2025-07-01)

Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups
by: D. V. Sidorenko, et al.
Published: (2024-04-01)

GalNT2-mediated O-glycosylation affects pancreas development and function in mice
by: Baris Mercanoglu, et al.
Published: (2024-11-01)

Non-alcoholic fatty liver disease and metabolic syndrome in overweight adolescents
by: Letícia Fregona Hungria de Moraes, et al.
Published: (2024-12-01)

Comparison of MR Spectroscopy, 2-Point Dixon, and Multi-Echo T2&ast; Sequences in Assessing Hepatic Fat Fraction Across a Diverse Range of Body Mass Index (BMI) and Waist Circumference Ratio (WCR) Values
by: Brzeska B, et al.
Published: (2025-02-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

Targeting Toll-like receptor 4 and microbiota dysregulation: a new frontier in nonalcoholic fatty liver disease management
by: K.B. Kvit
Published: (2024-12-01)

IRF8 aggravates nonalcoholic fatty liver disease via BMAL1/PPARγ axis
by: Xinyue Li, et al.
Published: (2025-05-01)

Assessing Pancreatic Fat and Its Correlation with Liver Fat in Suspected MASLD Patients Using Advanced Deep Learning Techniques from MRI Images
by: Hay Ching Cherrie Fung, et al.
Published: (2024-12-01)

FATTY LIVER DISEASE: SOME CHALLENGES OF STEATOMETRY (REVIEW)
by: Olga V. Kovaleva, et al.
Published: (2025-04-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

Identification of immune and major depressive disorder-related diagnostic markers for early nonalcoholic fatty liver disease by WGCNA and machine learning
by: Yuyun Jia, et al.
Published: (2025-06-01)

The interaction between nonalcoholic steatosis, anthropometric indicators and disturbance of lipid peroxidation and antioxidant defense in patients with signs of obesity.
by: A. Yu. Filippova
Published: (2017-01-01)

Atherogenic dyslipidemia and insulin resistance associated with nonalcohol hepatic steatosis: comparison, contrast, and differentiated therapy
by: L. B. Lazebnik, et al.
Published: (2009-06-01)

Positive association between proinsulin and fatty liver index in people with type 2 diabetes
by: Akinobu Nakamura, et al.
Published: (2024-02-01)

Beneficial effects of molasses extract in treatment of nonalcoholic fatty liver disease in high-fat diet-induced obese rats through regulation of lipid metabolism, bile acid, and oxidative stress
by: Sopita Wongphukhiaw, et al.
Published: (2025-08-01)